Skip to main content
logo
COSCIENS Biopharma Inc. (TSX:CSCI)
Canada flag Canada · Delayed Price · Currency is CAD
10.55
-0.46 (-4.18%)
Inactive · Last trade price on Jul 7, 2026

COSCIENS Biopharma Revenue

COSCIENS Biopharma had revenue of $1.89M USD in the quarter ending March 31, 2026, with 36.12% growth. This brings the company's revenue in the last twelve months to $8.00M, down -10.29% year-over-year. In the year 2025, COSCIENS Biopharma had annual revenue of $7.50M, down -21.79%.

Revenue (ttm)
$8.00M
Revenue Growth
-10.29%
P/S Ratio
1.05
Revenue / Employee
$285.68K
Employees
28
Market Cap
11.69M CAD

Revenue Chart

Chart
* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.50M-2.09M-21.79%
Dec 31, 20249.59M2.44M34.22%
Dec 31, 20237.14M-7.43M-50.98%
Dec 31, 202214.57M9.31M177.03%
Dec 31, 20215.26M1.61M44.03%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

COSCIENS Biopharma News

More News